Trial Profile
Efficacy and Safety of cetuximab with FOLFOX regimen as the first-line therapy in patients with KRAS wild-type advanced gastric cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 15 Dec 2015 New trial record
- 18 Jan 2014 Interim results presented at the 2014 Gastrointestinal Cancers Symposium